

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.24209763 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.03949912 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 4.73673051 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.69761135 |
| 5 | glutamate secretion (GO:0014047) | 4.60183415 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.42667291 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.37187144 |
| 8 | vocalization behavior (GO:0071625) | 4.11570920 |
| 9 | cerebellar granule cell differentiation (GO:0021707) | 4.08808844 |
| 10 | postsynaptic membrane organization (GO:0001941) | 4.04340437 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.04259056 |
| 12 | neurotransmitter secretion (GO:0007269) | 3.92656809 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.89322663 |
| 14 | regulation of synaptic vesicle transport (GO:1902803) | 3.85591837 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.80538230 |
| 16 | neuronal ion channel clustering (GO:0045161) | 3.78402031 |
| 17 | exploration behavior (GO:0035640) | 3.76724577 |
| 18 | protein localization to synapse (GO:0035418) | 3.74311456 |
| 19 | layer formation in cerebral cortex (GO:0021819) | 3.72667969 |
| 20 | establishment of mitochondrion localization (GO:0051654) | 3.60093077 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.59226942 |
| 22 | cellular potassium ion homeostasis (GO:0030007) | 3.51134446 |
| 23 | neuronal action potential propagation (GO:0019227) | 3.49355554 |
| 24 | gamma-aminobutyric acid transport (GO:0015812) | 3.48397301 |
| 25 | presynaptic membrane organization (GO:0097090) | 3.47196191 |
| 26 | proline transport (GO:0015824) | 3.46009564 |
| 27 | mating behavior (GO:0007617) | 3.44102430 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.40421408 |
| 29 | L-amino acid import (GO:0043092) | 3.34222681 |
| 30 | presynaptic membrane assembly (GO:0097105) | 3.33322585 |
| 31 | activation of protein kinase A activity (GO:0034199) | 3.30652151 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 3.30643183 |
| 33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.27493107 |
| 34 | sodium ion export (GO:0071436) | 3.26806167 |
| 35 | amino acid import (GO:0043090) | 3.26355713 |
| 36 | neurotransmitter transport (GO:0006836) | 3.23939490 |
| 37 | potassium ion import (GO:0010107) | 3.23825860 |
| 38 | auditory behavior (GO:0031223) | 3.21798096 |
| 39 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.16286681 |
| 40 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11485503 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.09477462 |
| 42 | regulation of neurotransmitter levels (GO:0001505) | 3.07865009 |
| 43 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.07854873 |
| 44 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05735577 |
| 45 | neuron recognition (GO:0008038) | 3.02928238 |
| 46 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.00991943 |
| 47 | detection of calcium ion (GO:0005513) | 3.00109782 |
| 48 | neuromuscular process controlling posture (GO:0050884) | 2.99213732 |
| 49 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98097282 |
| 50 | regulation of ARF protein signal transduction (GO:0032012) | 2.97851568 |
| 51 | positive regulation of dendritic spine development (GO:0060999) | 2.97073070 |
| 52 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94902334 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.94557514 |
| 54 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.93261437 |
| 55 | neuron-neuron synaptic transmission (GO:0007270) | 2.91719799 |
| 56 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.90737709 |
| 57 | innervation (GO:0060384) | 2.90262915 |
| 58 | synaptic transmission, glutamatergic (GO:0035249) | 2.90165594 |
| 59 | dendritic spine organization (GO:0097061) | 2.89898984 |
| 60 | regulation of vesicle fusion (GO:0031338) | 2.88820801 |
| 61 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.88645967 |
| 62 | mitochondrion transport along microtubule (GO:0047497) | 2.88645967 |
| 63 | transmission of nerve impulse (GO:0019226) | 2.88511489 |
| 64 | glutamate receptor signaling pathway (GO:0007215) | 2.88172204 |
| 65 | dendritic spine morphogenesis (GO:0060997) | 2.88093764 |
| 66 | cell communication by electrical coupling (GO:0010644) | 2.84790804 |
| 67 | axon ensheathment in central nervous system (GO:0032291) | 2.79441526 |
| 68 | central nervous system myelination (GO:0022010) | 2.79441526 |
| 69 | positive regulation of membrane potential (GO:0045838) | 2.78857638 |
| 70 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.77791298 |
| 71 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.77092989 |
| 72 | dendrite morphogenesis (GO:0048813) | 2.76921235 |
| 73 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.75540137 |
| 74 | acidic amino acid transport (GO:0015800) | 2.75080500 |
| 75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.74503905 |
| 76 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.74265168 |
| 77 | startle response (GO:0001964) | 2.73829215 |
| 78 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.72585436 |
| 79 | regulation of synapse maturation (GO:0090128) | 2.72222613 |
| 80 | positive regulation of synapse assembly (GO:0051965) | 2.71501316 |
| 81 | positive regulation of neurotransmitter transport (GO:0051590) | 2.71448436 |
| 82 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.71415127 |
| 83 | long-term memory (GO:0007616) | 2.70803108 |
| 84 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.69982125 |
| 85 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.69413771 |
| 86 | negative regulation of microtubule polymerization (GO:0031115) | 2.68750062 |
| 87 | vesicle transport along microtubule (GO:0047496) | 2.68518893 |
| 88 | regulation of neurotransmitter secretion (GO:0046928) | 2.68377085 |
| 89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.65909692 |
| 90 | axon cargo transport (GO:0008088) | 2.64490271 |
| 91 | organelle transport along microtubule (GO:0072384) | 2.64348146 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.63620821 |
| 93 | regulation of synaptic plasticity (GO:0048167) | 2.63164369 |
| 94 | regulation of postsynaptic membrane potential (GO:0060078) | 2.62422554 |
| 95 | synapse assembly (GO:0007416) | 2.62314594 |
| 96 | synaptic vesicle endocytosis (GO:0048488) | 2.62125590 |
| 97 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.61767351 |
| 98 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.61460139 |
| 99 | long-term synaptic potentiation (GO:0060291) | 2.59788554 |
| 100 | cellular sodium ion homeostasis (GO:0006883) | 2.59133142 |
| 101 | neuromuscular process controlling balance (GO:0050885) | 2.57837256 |
| 102 | prepulse inhibition (GO:0060134) | 2.56273475 |
| 103 | response to pheromone (GO:0019236) | 2.54909713 |
| 104 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.53984707 |
| 105 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.53984707 |
| 106 | response to auditory stimulus (GO:0010996) | 2.53947892 |
| 107 | axonal fasciculation (GO:0007413) | 2.53408663 |
| 108 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.52772899 |
| 109 | synaptic vesicle transport (GO:0048489) | 2.52295814 |
| 110 | establishment of synaptic vesicle localization (GO:0097480) | 2.52295814 |
| 111 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.51831931 |
| 112 | nucleobase catabolic process (GO:0046113) | 2.50450329 |
| 113 | membrane depolarization during action potential (GO:0086010) | 2.49283871 |
| 114 | regulation of neurotransmitter transport (GO:0051588) | 2.48770349 |
| 115 | cerebellar Purkinje cell layer development (GO:0021680) | 2.47382784 |
| 116 | alanine transport (GO:0032328) | 2.46665178 |
| 117 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.46614949 |
| 118 | potassium ion homeostasis (GO:0055075) | 2.46481192 |
| 119 | behavioral response to cocaine (GO:0048148) | 2.46226393 |
| 120 | membrane hyperpolarization (GO:0060081) | 2.45792082 |
| 121 | synapse organization (GO:0050808) | 2.44878849 |
| 122 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.43278884 |
| 123 | synaptic transmission (GO:0007268) | 2.43053706 |
| 124 | clathrin coat assembly (GO:0048268) | 2.42950715 |
| 125 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.42901310 |
| 126 | positive regulation of synapse maturation (GO:0090129) | 2.42376699 |
| 127 | cell migration in hindbrain (GO:0021535) | 2.39204960 |
| 128 | establishment of vesicle localization (GO:0051650) | 2.39031442 |
| 129 | membrane depolarization (GO:0051899) | 2.37659895 |
| 130 | regulation of glutamate secretion (GO:0014048) | 2.36361005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.36701780 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93016878 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90284447 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.86397080 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.63761534 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56309644 |
| 7 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53096869 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50225590 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46953504 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46953504 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45671114 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42981104 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41584123 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37634726 |
| 15 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23057975 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.19059142 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16771939 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16336068 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14112484 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.13757777 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.12582416 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.06117980 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96118617 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91442891 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88393402 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82581257 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73072545 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70901511 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70351027 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65493671 |
| 31 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.64794479 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.55551899 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52216529 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51572763 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50757993 |
| 36 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.48646581 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44908112 |
| 38 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42758779 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42211406 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36679118 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32006194 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29282981 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28888937 |
| 44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28220708 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24596836 |
| 46 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24041510 |
| 47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23974061 |
| 48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21648520 |
| 49 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20061337 |
| 50 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19107256 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18310678 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17898616 |
| 53 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16168910 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.16111114 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15453075 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13731380 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12505304 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12126092 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12108502 |
| 60 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12033229 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11184996 |
| 62 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09121256 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08814574 |
| 64 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07428582 |
| 65 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06169195 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05174300 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.03892754 |
| 68 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01748870 |
| 69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00940389 |
| 70 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00664499 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00462677 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00385769 |
| 73 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00365930 |
| 74 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.98718113 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97548679 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95279710 |
| 77 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95020575 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94378569 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94350221 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94199736 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94080731 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93526959 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93414210 |
| 84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92027569 |
| 85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91346174 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91194922 |
| 87 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90651292 |
| 88 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90578883 |
| 89 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89696512 |
| 90 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89369780 |
| 91 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89270268 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88693704 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88454849 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88251231 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88120134 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87358931 |
| 97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86852282 |
| 98 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86666245 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85676813 |
| 100 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85588382 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84353159 |
| 102 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84150921 |
| 103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83631908 |
| 104 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.83312276 |
| 105 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83015233 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.82599284 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81255080 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.80919721 |
| 109 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80200286 |
| 110 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.80117537 |
| 111 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.79869143 |
| 112 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.79527434 |
| 113 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.78928403 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.78761543 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78559046 |
| 116 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.78220603 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77588220 |
| 118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77392081 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75695057 |
| 120 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.75180147 |
| 121 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74133621 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73669236 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73669236 |
| 124 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73643035 |
| 125 | KDM2B_26808549_Chip-Seq_REH_Human | 0.73160950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.10511786 |
| 2 | MP0003880_abnormal_central_pattern | 4.19504853 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.54457249 |
| 4 | MP0004270_analgesia | 3.42248813 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.04143120 |
| 6 | MP0009745_abnormal_behavioral_response | 2.92390364 |
| 7 | MP0002064_seizures | 2.82505871 |
| 8 | MP0003329_amyloid_beta_deposits | 2.81449687 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.77401948 |
| 10 | MP0009046_muscle_twitch | 2.56241374 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.53512596 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.51268109 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.44239731 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.42722103 |
| 15 | MP0002822_catalepsy | 2.40349994 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.33991735 |
| 17 | MP0002272_abnormal_nervous_system | 2.32316113 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.31766333 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.28528227 |
| 20 | MP0002736_abnormal_nociception_after | 2.28161997 |
| 21 | MP0004858_abnormal_nervous_system | 2.13146754 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.09649952 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.07735810 |
| 24 | MP0001486_abnormal_startle_reflex | 2.06545356 |
| 25 | MP0001970_abnormal_pain_threshold | 2.01435549 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.93851236 |
| 27 | MP0001984_abnormal_olfaction | 1.84198101 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.83323131 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.82113547 |
| 30 | MP0003787_abnormal_imprinting | 1.76302822 |
| 31 | MP0000604_amyloidosis | 1.72914412 |
| 32 | MP0002184_abnormal_innervation | 1.70863394 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.66140337 |
| 34 | MP0004924_abnormal_behavior | 1.66140337 |
| 35 | MP0001905_abnormal_dopamine_level | 1.62241837 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.51364612 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.50805363 |
| 38 | MP0001529_abnormal_vocalization | 1.48959939 |
| 39 | MP0008569_lethality_at_weaning | 1.48250264 |
| 40 | MP0000955_abnormal_spinal_cord | 1.43864745 |
| 41 | MP0000778_abnormal_nervous_system | 1.39497053 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.37092800 |
| 43 | MP0005360_urolithiasis | 1.36761908 |
| 44 | MP0003633_abnormal_nervous_system | 1.34577702 |
| 45 | MP0003879_abnormal_hair_cell | 1.34474992 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.34221768 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.34217504 |
| 48 | MP0005535_abnormal_body_temperature | 1.29022139 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.27788946 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.24599577 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.23591983 |
| 52 | MP0004142_abnormal_muscle_tone | 1.21911338 |
| 53 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21862440 |
| 54 | MP0003123_paternal_imprinting | 1.20635603 |
| 55 | MP0004885_abnormal_endolymph | 1.20220671 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.19116358 |
| 57 | MP0005085_abnormal_gallbladder_physiolo | 1.19039640 |
| 58 | MP0002090_abnormal_vision | 1.18624042 |
| 59 | MP0003690_abnormal_glial_cell | 1.15405473 |
| 60 | MP0008872_abnormal_physiological_respon | 1.14169986 |
| 61 | MP0002229_neurodegeneration | 1.12469999 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.11305406 |
| 63 | MP0003631_nervous_system_phenotype | 1.10791112 |
| 64 | MP0003122_maternal_imprinting | 1.10284734 |
| 65 | MP0010386_abnormal_urinary_bladder | 1.05740430 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.05455646 |
| 67 | MP0001188_hyperpigmentation | 1.04875517 |
| 68 | MP0003634_abnormal_glial_cell | 1.04630522 |
| 69 | MP0005365_abnormal_bile_salt | 1.02483433 |
| 70 | MP0003195_calcinosis | 1.00227707 |
| 71 | MP0000920_abnormal_myelination | 0.99943345 |
| 72 | MP0002069_abnormal_eating/drinking_beha | 0.98888075 |
| 73 | MP0003121_genomic_imprinting | 0.97043208 |
| 74 | MP0008874_decreased_physiological_sensi | 0.91212887 |
| 75 | MP0008961_abnormal_basal_metabolism | 0.88774827 |
| 76 | MP0005083_abnormal_biliary_tract | 0.88599260 |
| 77 | MP0003632_abnormal_nervous_system | 0.83777562 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.82331162 |
| 79 | MP0000639_abnormal_adrenal_gland | 0.81804982 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.81533368 |
| 81 | MP0005623_abnormal_meninges_morphology | 0.81366613 |
| 82 | MP0002152_abnormal_brain_morphology | 0.79740800 |
| 83 | MP0004742_abnormal_vestibular_system | 0.78098976 |
| 84 | MP0000751_myopathy | 0.77611667 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 0.77210217 |
| 86 | MP0004043_abnormal_pH_regulation | 0.77172458 |
| 87 | MP0002653_abnormal_ependyma_morphology | 0.76535834 |
| 88 | MP0004130_abnormal_muscle_cell | 0.73704756 |
| 89 | MP0006072_abnormal_retinal_apoptosis | 0.73311460 |
| 90 | MP0001664_abnormal_digestion | 0.73190193 |
| 91 | MP0005332_abnormal_amino_acid | 0.72202257 |
| 92 | MP0005409_darkened_coat_color | 0.71703375 |
| 93 | MP0003075_altered_response_to | 0.71226801 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70883180 |
| 95 | MP0000569_abnormal_digit_pigmentation | 0.70002228 |
| 96 | MP0003172_abnormal_lysosome_physiology | 0.69358593 |
| 97 | MP0004147_increased_porphyrin_level | 0.67469632 |
| 98 | MP0005448_abnormal_energy_balance | 0.66635108 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.66278647 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.65507488 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.65266020 |
| 102 | MP0002752_abnormal_somatic_nervous | 0.65097498 |
| 103 | MP0003283_abnormal_digestive_organ | 0.65027113 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.64701819 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 0.64665108 |
| 106 | MP0001177_atelectasis | 0.63761205 |
| 107 | MP0003868_abnormal_feces_composition | 0.63379663 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 0.63341264 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.62567707 |
| 110 | MP0004085_abnormal_heartbeat | 0.62553534 |
| 111 | MP0000747_muscle_weakness | 0.62394369 |
| 112 | MP0001943_abnormal_respiration | 0.60749427 |
| 113 | MP0000026_abnormal_inner_ear | 0.60026044 |
| 114 | MP0005187_abnormal_penis_morphology | 0.58237688 |
| 115 | MP0001958_emphysema | 0.58156020 |
| 116 | MP0010769_abnormal_survival | 0.57159222 |
| 117 | MP0002082_postnatal_lethality | 0.54818931 |
| 118 | MP0010770_preweaning_lethality | 0.54818931 |
| 119 | MP0003861_abnormal_nervous_system | 0.54419916 |
| 120 | MP0003183_abnormal_peptide_metabolism | 0.53401852 |
| 121 | MP0010768_mortality/aging | 0.52982142 |
| 122 | MP0001299_abnormal_eye_distance/ | 0.51772642 |
| 123 | MP0004510_myositis | 0.50512388 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.50349888 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.50234933 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.49157947 |
| 127 | MP0005394_taste/olfaction_phenotype | 0.48590490 |
| 128 | MP0005499_abnormal_olfactory_system | 0.48590490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.50607285 |
| 2 | Focal motor seizures (HP:0011153) | 5.25675523 |
| 3 | Visual hallucinations (HP:0002367) | 4.63977558 |
| 4 | Focal seizures (HP:0007359) | 4.37633946 |
| 5 | Atonic seizures (HP:0010819) | 3.84903246 |
| 6 | Supranuclear gaze palsy (HP:0000605) | 3.82794879 |
| 7 | Neurofibrillary tangles (HP:0002185) | 3.69104142 |
| 8 | Pheochromocytoma (HP:0002666) | 3.66837873 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.56081304 |
| 10 | Action tremor (HP:0002345) | 3.55418249 |
| 11 | Absence seizures (HP:0002121) | 3.51329618 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.40678627 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 3.35136967 |
| 14 | Ankle clonus (HP:0011448) | 3.31036703 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.27375199 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 3.24996501 |
| 17 | Dialeptic seizures (HP:0011146) | 3.08533826 |
| 18 | Limb dystonia (HP:0002451) | 3.00761275 |
| 19 | Anxiety (HP:0000739) | 2.97957644 |
| 20 | Abnormal eating behavior (HP:0100738) | 2.96636165 |
| 21 | Termporal pattern (HP:0011008) | 2.93999605 |
| 22 | Insidious onset (HP:0003587) | 2.93999605 |
| 23 | Febrile seizures (HP:0002373) | 2.92744814 |
| 24 | Depression (HP:0000716) | 2.91212671 |
| 25 | Obstructive sleep apnea (HP:0002870) | 2.90906089 |
| 26 | Agitation (HP:0000713) | 2.76659770 |
| 27 | Spastic gait (HP:0002064) | 2.76117156 |
| 28 | Progressive inability to walk (HP:0002505) | 2.72091348 |
| 29 | Mutism (HP:0002300) | 2.72001672 |
| 30 | Truncal ataxia (HP:0002078) | 2.70573178 |
| 31 | Urinary urgency (HP:0000012) | 2.68792573 |
| 32 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.66835000 |
| 33 | Peripheral hypomyelination (HP:0007182) | 2.66579956 |
| 34 | Abnormality of the corticospinal tract (HP:0002492) | 2.63770390 |
| 35 | Torticollis (HP:0000473) | 2.60017529 |
| 36 | Polyphagia (HP:0002591) | 2.57641400 |
| 37 | Dysmetria (HP:0001310) | 2.55254504 |
| 38 | Hyperventilation (HP:0002883) | 2.55208518 |
| 39 | Postural instability (HP:0002172) | 2.53654280 |
| 40 | Intention tremor (HP:0002080) | 2.53638603 |
| 41 | Poor eye contact (HP:0000817) | 2.51071334 |
| 42 | Impaired social interactions (HP:0000735) | 2.49689623 |
| 43 | Abnormal social behavior (HP:0012433) | 2.49689623 |
| 44 | Apathy (HP:0000741) | 2.48155898 |
| 45 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.46102751 |
| 46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.45717560 |
| 47 | Scanning speech (HP:0002168) | 2.44604926 |
| 48 | Sleep apnea (HP:0010535) | 2.42351751 |
| 49 | Focal dystonia (HP:0004373) | 2.41419148 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.38258639 |
| 51 | Dysdiadochokinesis (HP:0002075) | 2.37522792 |
| 52 | EEG with generalized epileptiform discharges (HP:0011198) | 2.36740595 |
| 53 | Craniofacial dystonia (HP:0012179) | 2.34347563 |
| 54 | Epileptiform EEG discharges (HP:0011182) | 2.32487307 |
| 55 | Diminished motivation (HP:0000745) | 2.32122135 |
| 56 | Cerebral hemorrhage (HP:0001342) | 2.28900547 |
| 57 | Papilledema (HP:0001085) | 2.27365559 |
| 58 | Hypsarrhythmia (HP:0002521) | 2.26072852 |
| 59 | Status epilepticus (HP:0002133) | 2.25832346 |
| 60 | Abnormality of the lower motor neuron (HP:0002366) | 2.23767306 |
| 61 | Bradykinesia (HP:0002067) | 2.22199895 |
| 62 | Lower limb muscle weakness (HP:0007340) | 2.18157280 |
| 63 | Diplopia (HP:0000651) | 2.17273622 |
| 64 | Abnormality of binocular vision (HP:0011514) | 2.17273622 |
| 65 | Failure to thrive in infancy (HP:0001531) | 2.14789015 |
| 66 | Megalencephaly (HP:0001355) | 2.14584437 |
| 67 | Hammertoe (HP:0001765) | 2.14500406 |
| 68 | Amyotrophic lateral sclerosis (HP:0007354) | 2.13904161 |
| 69 | Amblyopia (HP:0000646) | 2.12452195 |
| 70 | Drooling (HP:0002307) | 2.11935512 |
| 71 | Excessive salivation (HP:0003781) | 2.11935512 |
| 72 | Delusions (HP:0000746) | 2.09224489 |
| 73 | Annular pancreas (HP:0001734) | 2.08264056 |
| 74 | Insomnia (HP:0100785) | 2.07553769 |
| 75 | Clonus (HP:0002169) | 2.07023202 |
| 76 | Rigidity (HP:0002063) | 2.06344385 |
| 77 | Hypercortisolism (HP:0001578) | 2.06100315 |
| 78 | Hemiparesis (HP:0001269) | 2.05475110 |
| 79 | Psychosis (HP:0000709) | 2.04152102 |
| 80 | Akinesia (HP:0002304) | 2.01522536 |
| 81 | Split foot (HP:0001839) | 2.00925523 |
| 82 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.00190485 |
| 83 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.98014589 |
| 84 | Inability to walk (HP:0002540) | 1.96490927 |
| 85 | Broad-based gait (HP:0002136) | 1.96245383 |
| 86 | Fetal akinesia sequence (HP:0001989) | 1.95780605 |
| 87 | Deep venous thrombosis (HP:0002625) | 1.95448753 |
| 88 | Hemiplegia (HP:0002301) | 1.95114544 |
| 89 | Growth hormone excess (HP:0000845) | 1.94537676 |
| 90 | Spinal canal stenosis (HP:0003416) | 1.93564666 |
| 91 | Hypoventilation (HP:0002791) | 1.93536001 |
| 92 | Absent speech (HP:0001344) | 1.93357416 |
| 93 | Retinal dysplasia (HP:0007973) | 1.92703386 |
| 94 | Generalized myoclonic seizures (HP:0002123) | 1.91554626 |
| 95 | Mild short stature (HP:0003502) | 1.89679304 |
| 96 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89365666 |
| 97 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89365666 |
| 98 | Ketoacidosis (HP:0001993) | 1.89334624 |
| 99 | Gaze-evoked nystagmus (HP:0000640) | 1.89085778 |
| 100 | Turricephaly (HP:0000262) | 1.86104148 |
| 101 | Ventricular fibrillation (HP:0001663) | 1.86047830 |
| 102 | Tetraplegia (HP:0002445) | 1.85392447 |
| 103 | Hand muscle atrophy (HP:0009130) | 1.84272177 |
| 104 | Postural tremor (HP:0002174) | 1.83996008 |
| 105 | Increased circulating renin level (HP:0000848) | 1.83733542 |
| 106 | Gout (HP:0001997) | 1.83602110 |
| 107 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83012202 |
| 108 | Heterochromia iridis (HP:0001100) | 1.81518437 |
| 109 | Rapidly progressive (HP:0003678) | 1.80873527 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 1.80669958 |
| 111 | Spastic tetraparesis (HP:0001285) | 1.80135692 |
| 112 | Gait ataxia (HP:0002066) | 1.79137463 |
| 113 | Blue irides (HP:0000635) | 1.78976914 |
| 114 | Spastic tetraplegia (HP:0002510) | 1.78922459 |
| 115 | Poor suck (HP:0002033) | 1.78273489 |
| 116 | Lower limb asymmetry (HP:0100559) | 1.77666155 |
| 117 | Type II lissencephaly (HP:0007260) | 1.76198779 |
| 118 | Sensorimotor neuropathy (HP:0007141) | 1.75942712 |
| 119 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.75725459 |
| 120 | Stereotypic behavior (HP:0000733) | 1.74054185 |
| 121 | Bundle branch block (HP:0011710) | 1.73235009 |
| 122 | Abnormality of pain sensation (HP:0010832) | 1.72268933 |
| 123 | Impaired pain sensation (HP:0007328) | 1.72268933 |
| 124 | Foot dorsiflexor weakness (HP:0009027) | 1.72205834 |
| 125 | Impaired vibratory sensation (HP:0002495) | 1.70855794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.81722320 |
| 2 | NTRK3 | 3.79913271 |
| 3 | MARK1 | 3.33409367 |
| 4 | EPHA4 | 2.90497471 |
| 5 | MINK1 | 2.81174957 |
| 6 | MAP3K4 | 2.71220893 |
| 7 | MAP3K12 | 2.52733239 |
| 8 | NTRK1 | 2.47233749 |
| 9 | KSR2 | 2.43510784 |
| 10 | PAK6 | 2.24123632 |
| 11 | MAP2K7 | 2.21731013 |
| 12 | MAP2K4 | 2.06566050 |
| 13 | DAPK2 | 2.02778669 |
| 14 | NTRK2 | 1.98099090 |
| 15 | RIPK1 | 1.85367480 |
| 16 | ARAF | 1.79405766 |
| 17 | MAP3K2 | 1.65805411 |
| 18 | CAMKK1 | 1.55376718 |
| 19 | GRK5 | 1.52098208 |
| 20 | CDK5 | 1.49377437 |
| 21 | KSR1 | 1.48692097 |
| 22 | LMTK2 | 1.42122674 |
| 23 | PHKG2 | 1.38886599 |
| 24 | PHKG1 | 1.38886599 |
| 25 | PRKD3 | 1.36907391 |
| 26 | PNCK | 1.36579956 |
| 27 | PAK3 | 1.24982844 |
| 28 | CAMKK2 | 1.24668932 |
| 29 | UHMK1 | 1.23577608 |
| 30 | RET | 1.20994056 |
| 31 | PRKCG | 1.19542962 |
| 32 | CSNK1G2 | 1.13377683 |
| 33 | RIPK4 | 1.12567780 |
| 34 | MAP3K13 | 1.10825777 |
| 35 | PRPF4B | 1.09979873 |
| 36 | TYRO3 | 1.07213219 |
| 37 | TNIK | 1.06851298 |
| 38 | PRKCH | 1.06594781 |
| 39 | MAPK13 | 1.06283702 |
| 40 | LATS2 | 1.05043721 |
| 41 | TESK1 | 1.04022427 |
| 42 | WNK4 | 1.01568406 |
| 43 | MOS | 1.00105129 |
| 44 | CDK14 | 0.97399870 |
| 45 | DAPK1 | 0.96713334 |
| 46 | CASK | 0.96525555 |
| 47 | PLK2 | 0.93699082 |
| 48 | CDK19 | 0.92457347 |
| 49 | SIK2 | 0.91957575 |
| 50 | SCYL2 | 0.91731911 |
| 51 | CAMK2A | 0.91221643 |
| 52 | OXSR1 | 0.91102747 |
| 53 | CDK18 | 0.88933938 |
| 54 | MAP3K1 | 0.88378977 |
| 55 | FES | 0.88235481 |
| 56 | STK38 | 0.87936161 |
| 57 | CDK15 | 0.87059969 |
| 58 | EPHA3 | 0.84706638 |
| 59 | WNK3 | 0.83363792 |
| 60 | SGK494 | 0.82973980 |
| 61 | SGK223 | 0.82973980 |
| 62 | LIMK1 | 0.81187391 |
| 63 | STK39 | 0.80685442 |
| 64 | CAMK2B | 0.75205595 |
| 65 | RAF1 | 0.75152920 |
| 66 | CSNK1G3 | 0.74289704 |
| 67 | CDK11A | 0.73818217 |
| 68 | MAPK12 | 0.73159706 |
| 69 | FER | 0.72808137 |
| 70 | CAMK2G | 0.71069421 |
| 71 | EPHB2 | 0.67680221 |
| 72 | MAP2K1 | 0.66726034 |
| 73 | CAMK4 | 0.65665324 |
| 74 | NEK6 | 0.64085533 |
| 75 | PRKCZ | 0.62500873 |
| 76 | DYRK2 | 0.60848154 |
| 77 | DYRK1A | 0.60823828 |
| 78 | MAPK10 | 0.60689057 |
| 79 | PDPK1 | 0.60368059 |
| 80 | PDK1 | 0.59450201 |
| 81 | CAMK2D | 0.58093319 |
| 82 | TAOK1 | 0.57739793 |
| 83 | PINK1 | 0.57701149 |
| 84 | ERBB3 | 0.56318273 |
| 85 | STK11 | 0.55098844 |
| 86 | PRKCE | 0.54653987 |
| 87 | PTK2B | 0.54567989 |
| 88 | CAMK1 | 0.54100545 |
| 89 | EPHB1 | 0.54020100 |
| 90 | FYN | 0.53792897 |
| 91 | DYRK1B | 0.52973272 |
| 92 | PKN1 | 0.52780068 |
| 93 | TNK2 | 0.52599990 |
| 94 | MARK2 | 0.51146306 |
| 95 | BCR | 0.49776568 |
| 96 | WNK1 | 0.49065682 |
| 97 | PDGFRA | 0.48791460 |
| 98 | CAMK1G | 0.47189832 |
| 99 | PTK2 | 0.46918098 |
| 100 | MAPKAPK5 | 0.46741518 |
| 101 | FGFR2 | 0.45975438 |
| 102 | ROCK2 | 0.45462481 |
| 103 | FGFR4 | 0.42664541 |
| 104 | RPS6KA2 | 0.41691950 |
| 105 | MAP3K11 | 0.41045533 |
| 106 | SIK3 | 0.39764543 |
| 107 | SGK2 | 0.39326928 |
| 108 | CSNK1G1 | 0.39270245 |
| 109 | ERBB2 | 0.38595043 |
| 110 | SGK1 | 0.36484273 |
| 111 | CSNK1A1L | 0.36417360 |
| 112 | RPS6KA3 | 0.36054639 |
| 113 | SRC | 0.35672446 |
| 114 | MAP2K6 | 0.35306695 |
| 115 | ALK | 0.35131084 |
| 116 | PRKACG | 0.35106866 |
| 117 | FGR | 0.34273264 |
| 118 | IRAK2 | 0.34183344 |
| 119 | NME1 | 0.34070191 |
| 120 | SGK3 | 0.33789856 |
| 121 | JAK2 | 0.31021151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.26024933 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.84255507 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.34679119 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.34570059 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.10275649 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.97935801 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 1.93691563 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 1.91008815 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.88915979 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.88810802 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.88178567 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.83308273 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.82807199 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.81656440 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.78230048 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.77682084 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.75765226 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.64284836 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53522004 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.50902594 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48864174 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43301409 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41074353 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.39561265 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.39108408 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38708008 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.32228500 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.31144244 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.26397500 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.24899308 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.23587368 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16459332 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.15565802 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.13201526 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.12679719 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.11009005 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05320328 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.04652719 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00374671 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99871849 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98060781 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98013732 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97737662 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96624173 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 0.92942976 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88953807 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87919107 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86265805 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.86095879 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82744080 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.81490661 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.81453142 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 0.80766968 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79137821 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78260453 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76005611 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75285385 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73877891 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73800014 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73767504 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73732057 |
| 62 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72640060 |
| 63 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69077623 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66583660 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66188568 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66015402 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65730007 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65046968 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64930343 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64152972 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63380954 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61597465 |
| 73 | Melanogenesis_Homo sapiens_hsa04916 | 0.60846640 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59856990 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58830383 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58496523 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57132683 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.56799111 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56205556 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55908160 |
| 81 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55303828 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54760845 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54070893 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52755818 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.51303248 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50863664 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48560128 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47438782 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47418795 |
| 90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46672364 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46484139 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46396253 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45208183 |
| 94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44514041 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44198414 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43082639 |
| 97 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42759356 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42697190 |
| 99 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41256810 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.40299410 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40262078 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39487389 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39210161 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38656336 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38349782 |
| 106 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38257964 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37665456 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36868643 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36570628 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36358313 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36197150 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36193043 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35773783 |
| 114 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35134781 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34724189 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34392332 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34264008 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33870344 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32884449 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32354235 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32119686 |
| 122 | Tight junction_Homo sapiens_hsa04530 | 0.31876893 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31818641 |
| 124 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31256555 |
| 125 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29743255 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29570558 |
| 127 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29222972 |

